• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cosmos Health Inc. - Common Stock (NQ:COSM)

    1.080 -0.010 (-0.92%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cosmos Health Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
    Via ACCESSWIRE
    Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today?
    Cosmos Health Inc (NASDAQ: COSM) announced its inaugural 2026 revenue and  
    Via Benzinga
    Taglich Brothers Initiates Coverage of Cosmos Health Inc.
    Via ACCESSWIRE
    Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
    Via ACCESSWIRE
    Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
    Via ACCESSWIRE
    Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
    Via ACCESSWIRE
    Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
    Via ACCESSWIRE
    Cosmos Health Announces Open Market Stock Purchases by the CEO
    Via ACCESSWIRE
    Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
    Via ACCESSWIRE
    Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
    Via ACCESSWIRE
    Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
    Via ACCESSWIRE
    Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
    Via ACCESSWIRE
    Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades. 
    Via Benzinga
    Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
    Via ACCESSWIRE
    COSMOS HEALTH CEO Issues Letter to Shareholders
    Via ACCESSWIRE
    Ticking Time Bombs: 3 Healthcare Stocks to Dump Before the Damage Is Done
    The healthcare industry has historically provided good returns to investors, however there are also healthcare stocks you will want to sell. 
    Via InvestorPlace
    Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
    Via ACCESSWIRE
    Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
    Via ACCESSWIRE
    Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care &amp; Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
    Via ACCESSWIRE
    Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
    Via ACCESSWIRE
    Cosmos Health Starts Stock Buyback Program
    Via ACCESSWIRE
    BestGrowthStocks.com issues New Growth Report on Cosmos Health
    --News Direct-- 
    Via News Direct
    BestGrowthStocks.com issues New Growth Report on Cosmos Health
    NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks... 
    Via TheNewswire.com
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
    Via ACCESSWIRE
    Cosmos Health Q2: Revenues Slip 6%, Unfavorable Forex, Positive Adjusted EBITDA & More
    Cosmos Health Inc. (NASDAQ: COSM) reported 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.